首页> 外文OA文献 >Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
【2h】

Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX

机译:Carbonic Anydrase IX的代谢转运蛋白和迁移/侵袭的协调调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypoxia is a prominent feature of the tumor microenvironment (TME) and cancer cells must dynamically adapt their metabolism to survive in these conditions. A major consequence of metabolic rewiring by cancer cells in hypoxia is the accumulation of acidic metabolites, leading to the perturbation of intracellular pH (pHi) homeostasis and increased acidosis in the TME. To mitigate the potentially detrimental consequences of an increasingly hypoxic and acidic TME, cancer cells employ a network of enzymes and transporters to regulate pH, particularly the extracellular facing carbonic anhydrase IX (CAIX) and CAXII. In addition to the role that these CAs play in the regulation of pH, recent proteome-wide analyses have revealed the presence of a complex CAIX interactome in cancer cells with roles in metabolite transport, tumor cell migration and invasion. Here, we explore the potential contributions of these interactions to the metabolic landscape of tumor cells in hypoxia and discuss the role of CAIX as a hub for the coordinated regulation of metabolic, migratory and invasive processes by cancer cells. We also discuss recent work targeting CAIX activity using highly selective small molecule inhibitors and briefly discuss ongoing clinical trials involving SLC-0111, a lead candidate small molecule inhibitor of CAIX/CAXII.
机译:缺氧是肿瘤微环境(TME)和癌细胞的一个突出的特点必须动态地适应其代谢在这些条件中生存。代谢重新布线的缺氧一个主要后果由癌细胞是酸性代谢产物的积累,导致细胞内pH值(PHI)稳态的扰动并增加酸中毒在TME。为了减轻日益缺氧和酸性TME的潜在的有害后果,癌细胞使用酶和转运蛋白的一个网络,以调节pH值,特别是面对碳酸酐酶IX(CAIX)和CAXII细胞外。除此之外这些CA在pH值调节中发挥的作用,最近的全蛋白质组分析揭示了一个复杂的相互作用组CAIX癌细胞中存在与代谢产物的运输,肿瘤细胞迁移和侵袭的作用。在这里,我们探讨这些相互作用的肿瘤细胞处于缺氧代谢景观的潜在贡献,并讨论为癌细胞代谢,迁移和侵袭过程的协同调控的枢纽CAIX的作用。我们还讨论了近期的工作中使用高选择性的小分子抑制剂,并简要讨论涉及正在进行的临床试验靶向CAIX活性SLC-0111,CAIX / CAXII的先导候选小分子抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号